Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemosensitivity testing in malignant melanoma.

Selma Ugurel1, Wolfgang Tilgen, Uwe Reinhold

  • 1Department of Dermatology, The Saarland University Hospital, 66421 Homburg/Saar, Germany.

Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|January 17, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mobile electromagnetic levitator for time-resolved in situ X-ray diffraction studies of high-temperature phase transformations.

Journal of synchrotron radiation·2026
Same author

Real-world effectiveness and safety with nivolumab plus ipilimumab or nivolumab alone in patients with or without melanoma brain metastasis: Results from the German noninterventional NICO study.

International journal of cancer·2026
Same author

Real-world data on anti-PD-1 plus lenvatinib as a treatment option in pretreated advanced melanoma patients - a retrospective DeCOG study.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Treatment patterns in geriatric patients with melanoma and the effect of age on the efficacy of immunotherapy: Analysis from the real-world multicenter registry ADOREG.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Melanoma of unknown primary shows an oncogenic pattern and clinical course of sun-exposed melanoma.

The British journal of dermatology·2026
Same author

Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same journal

Future Challenges of Molecular Imaging in Oncology.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
Same journal

Clinical Applications of Theranostics.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
Same journal

Internal Radiation Therapy.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
Same journal

The Role of Molecular Imaging in Ion Beam Therapy.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
Same journal

Molecular Imaging in Photon Radiotherapy.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
Same journal

Advancements in Intraoperative Imaging for Enhanced Surgical Precision.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
See all related articles

An ATP-based chemosensitivity assay (ATP-TCA) can predict which metastatic melanoma patients benefit from tailored chemotherapy. This in vitro test identifies optimal drug combinations, improving treatment selection for poor-prognosis patients.

Area of Science:

  • Oncology
  • Pharmacology
  • Biotechnology

Background:

  • Metastatic melanoma has a poor prognosis with limited treatment efficacy.
  • Current chemotherapy regimens offer low response rates and minimal survival benefits.
  • There is a need for personalized treatment strategies in metastatic melanoma.

Purpose of the Study:

  • To evaluate an in vitro ATP-based chemosensitivity assay (ATP-TCA) for predicting drug sensitivity in melanoma.
  • To assess the efficacy of various anticancer drugs and combinations using ATP-TCA.
  • To determine if ATP-TCA can guide individualized chemotherapy selection for metastatic melanoma patients.

Main Methods:

  • Tumor tissue specimens from 31 metastatic melanoma patients were analyzed.
  • An ATP-based chemosensitivity assay (ATP-TCA) utilizing a luminescence assay was employed.

Related Experiment Videos

  • Eight anticancer drugs were tested individually and in combination to determine chemosensitivity indices.

    • Main Results:

    • Significant heterogeneity in chemosensitivity was observed across melanoma tissue samples.
    • The combination of treosulfan and gemcitabine showed the highest sensitivity (76%).
    • Other effective combinations included paclitaxel/doxorubicin (66%) and gemcitabine/cisplatin (55%).

    Conclusions:

    • The ATP-TCA is a viable tool for assessing individual melanoma cell drug sensitivity.
    • This assay can aid in selecting patients who may benefit from personalized cytostatic therapy.
    • A multicenter trial is underway to validate the predictive value of ATP-TCA in clinical practice.